Literature DB >> 8835502

HLA-B27 and bacteria.

J Uksila1, P Toivanen.   

Abstract

Most HLA-B27 positive individuals live without noticing the risk factor they carry. Only when certain bacteria come into play, usually in the form of intestinal or genital infection, some of the HLA-B27 positive individuals will develop a reactive disease. Such an association is so well established that it has formed a basis to study the relation of autoimmune reactions to microbial infections. Early epidemiological investigations have been followed by studies on immunological cross-reactivity and recently by studies on presentation of bacterial peptides by the HLA-B27 molecule. This introductory review briefly summarizes the evolution of the research, the goal of which still remains to clarify the etiopathogenetic mechanisms of HLA-B27 associated diseases.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8835502     DOI: 10.1007/bf03342645

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  26 in total

1.  Identification of self peptides bound to purified HLA-B27.

Authors:  T S Jardetzky; W S Lane; R A Robinson; D R Madden; D C Wiley
Journal:  Nature       Date:  1991-09-26       Impact factor: 49.962

2.  Anti-HLA-B27 antibodies in sera from patients with gram-negative bacterial infections.

Authors:  D Cavender; M Ziff
Journal:  Arthritis Rheum       Date:  1986-03

3.  Cross-reactive epitope with Klebsiella pneumoniae nitrogenase in articular tissue of HLA-B27+ patients with ankylosing spondylitis.

Authors:  G Husby; N Tsuchiya; P L Schwimmbeck; A Keat; J A Pahle; M B Oldstone; R C Williams
Journal:  Arthritis Rheum       Date:  1989-04

4.  Ankylosing spondylitis: klebsiella and HL-A B27.

Authors:  R Ebringer; D Cooke; D R Cawdell; P Cowling; A Ebringer
Journal:  Rheumatol Rehabil       Date:  1977-08

5.  HLA-B27-restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis.

Authors:  E Hermann; D T Yu; K H Meyer zum Büschenfelde; B Fleischer
Journal:  Lancet       Date:  1993-09-11       Impact factor: 79.321

6.  Serum antibodies from patients with ankylosing spondylitis and Reiter's syndrome are reactive with HLA-B27 cells transfected with the Mycobacterium tuberculosis hsp60 gene.

Authors:  H Kellner; J Wen; J Wang; R B Raybourne; K M Williams; D T Yu
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

7.  Antibodies to Klebsiella pneumoniae, Escherichia coli and Proteus mirabilis in the sera of patients with axial and peripheral form of ankylosing spondylitis.

Authors:  O Mäki-Ikola; M Nissilä; K Lehtinen; M Leirisalo-Repo; P Toivanen; K Granfors
Journal:  Br J Rheumatol       Date:  1995-05

8.  Molecular mimickry between HLA B27 and Yersinia, Salmonella, Shigella and Klebsiella within the same region of HLA alpha 1-helix.

Authors:  R Lahesmaa; M Skurnik; M Vaara; M Leirisalo-Repo; M Nissilä; K Granfors; P Toivanen
Journal:  Clin Exp Immunol       Date:  1991-12       Impact factor: 4.330

9.  Antibodies to Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis in ankylosing spondylitis: effect of sulfasalazine treatment.

Authors:  M Nissilä; R Lahesmaa; M Leirisalo-Repo; K Lehtinen; P Toivanen; K Granfors
Journal:  J Rheumatol       Date:  1994-11       Impact factor: 4.666

10.  Intestinal permeability in patients with yersinia triggered reactive arthritis.

Authors:  R Lahesmaa-Rantala; K E Magnusson; K Granfors; R Leino; T Sundqvist; A Toivanen
Journal:  Ann Rheum Dis       Date:  1991-02       Impact factor: 19.103

View more
  1 in total

1.  Bartonella henselae associated uveitis and HLA-B27.

Authors:  F T Kerkhoff; A Rothova
Journal:  Br J Ophthalmol       Date:  2000-10       Impact factor: 4.638

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.